Literature DB >> 11018534

Structure-based sequence alignment for the beta-trefoil subdomain of the clostridial neurotoxin family provides residue level information about the putative ganglioside binding site.

K Ginalski1, C Venclovas, B Lesyng, K Fidelis.   

Abstract

Clostridial neurotoxins embrace a family of extremely potent toxins comprised of tetanus toxin (TeNT) and seven different serotypes of botulinum toxin (BoNT/A-G). The beta-trefoil subdomain of the C-terminal part of the heavy chain (H(C)), responsible for ganglioside binding, is the most divergent region in clostridial neurotoxins with sequence identity as low as 15%. We re-examined the alignment between family sequences within this subdomain, since in this region all alignments published to date show obvious inconsistencies with the beta-trefoil fold. The final alignment was obtained by considering the general constraints imposed by this fold, and homology modeling studies based on the TeNT structure. Recently solved structures of BoNT/A confirm the validity of this structure-based approach. Taking into account biochemical data and crystal structures of TeNT and BoNT/A, we also re-examined the location of the putative ganglioside binding site and, using the new alignment, characterized this site in other BoNT serotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018534     DOI: 10.1016/s0014-5793(00)01954-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.

Authors:  B Vijayalakshmi Ayyar; K Roger Aoki; M Zouhair Atassi
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

2.  Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication.

Authors:  Sangmu Jun; Beata Clapp; Dagmara Zlotkowska; Teri Hoyt; Kathryn Holderness; Massimo Maddaloni; David W Pascual
Journal:  Int Immunol       Date:  2011-12-29       Impact factor: 4.823

Review 3.  Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.

Authors:  Kwok-Ho Lam; Guorui Yao; Rongsheng Jin
Journal:  Prog Biophys Mol Biol       Date:  2015-02-19       Impact factor: 3.667

4.  Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

Authors:  Roland W M Bullens; Graham M O'Hanlon; Eric Wagner; Peter C Molenaar; Keiko Furukawa; Koichi Furukawa; Jaap J Plomp; Hugh J Willison
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

5.  Adenovirus F protein as a delivery vehicle for botulinum B.

Authors:  Beata Clapp; Sarah Golden; Massimo Maddaloni; Herman F Staats; David W Pascual
Journal:  BMC Immunol       Date:  2010-07-07       Impact factor: 3.615

Review 6.  Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function.

Authors:  Audrey Fischer; Mauricio Montal
Journal:  Toxicon       Date:  2013-02-05       Impact factor: 3.033

7.  Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits.

Authors:  Herman F Staats; Jeffrey R Fielhauer; Afton L Thompson; Alice A Tripp; Ashley E Sobel; Massimo Maddaloni; Soman N Abraham; David W Pascual
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.